Hyderabad-based Natco Pharma Limited, on December 21, received the approval from Food & Drug Administration (FDA) for marketing the prescription version of Lanzoprazole, CFO of the company Bhaskar Narayana told CNBC-TV18 in an interview.
first published: Feb 14, 2013 02:44 pm
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty break 3-day losing streak as Trump walks back on EU tariffs? | Opening Bell
Why India needs to rethink protectionism and bring in capital market reforms - Jahangir Aziz
Trump Hints at Big India-US Trade Deal | Moneycontrol MEGA Exclusive
Live: Davos 2026 Day 3 Highlights | AI, India Deals & Global CEO Voices
